Patients For Affordable Drugs NOW Endorses Washington Drug Price Transparency Measure

Patients For Affordable Drugs NOW Endorses Washington Drug Price Transparency Measure Washington patient: “I haven’t taken insulin in over a month because of the cost of the drug.”

OLYMPIA, WA — Today’s state Senate hearing on the drug pricing transparency measure HB1541 brings Washingtonians one step closer to lowering drug prices. Patients For Affordable Drugs NOW, a bipartisan national patient organization advocating for policies to lower drug prices, announced it’s strong support for the legislation and said it will take action to push for passage.

“Washington patients tell us devastating stories of skipping doses, cutting pills in half, and going into bankruptcy due to the skyrocketing price of prescription drugs. That’s why this bill is so important,” said David Mitchell, a cancer patient whose drugs cost $450,000 last year and the founder of Patients For Affordable Drugs NOW.

One of those patients is Vancouver resident, Carolyn Wilson. The retired radiology instructor will testify in the Monday morning hearing about the struggles she and her children have faced affording prescription drugs.

“I used to be a Radiology instructor. I’d watch patients come in with swollen arms and legs due to not taking their insulin,” she said in planned testimony “Now, I’m scared that will happen to me. I haven’t taken insulin in over a month because of the cost of the drug.

Wilson will testify about the transparency measure at a public hearing 10 a.m. Monday in Senate Hearing Room 1, in the John A. Cherberg Building, 304 15th Avenue SW.

The bipartisan bill would shed much-needed light on drug prices by requiring drug corporations to justify price hikes to state officials and residents. If passed, drug corporations won’t be able to blindside Washingtonians with arbitrary price hikes.

Without this information consumers and policymakers are at a disadvantage in the ability to engage in real discussions aimed at achieving more sustainable pricing. This move towards transparency can help further discussions about how we address prices in the long term.

Patients For Affordable Drugs NOW is a bipartisan advocacy organization focused exclusively on policies to lower drug prices. To maintain its independence, the group does not accept funding  from organizations that profit from the development or distribution of prescription drugs.

For Washington patient interviews or a copy of the testimony, contact Juliana Keeping juliana@patientsforafforedabledrugs.org

###